160 related articles for article (PubMed ID: 12136073)
1. Multifocal motor neuropathy and Campylobacter jejuni reactivity.
Terenghi F; Allaria S; Scarlato G; Nobile-Orazio E
Neurology; 2002 Jul; 59(2):282-4. PubMed ID: 12136073
[TBL] [Abstract][Full Text] [Related]
2. Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease.
Nevo Y; Pestronk A
J Infect Dis; 1997 Dec; 176 Suppl 2():S154-6. PubMed ID: 9396701
[TBL] [Abstract][Full Text] [Related]
3. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
[No Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin for cranial polyneuropathy associated with Campylobacter jejuni infection.
Wakamoto H; Ohta M; Nakano N; Tagawa M; Shiraishi T
Pediatr Neurol; 2001 Oct; 25(4):325-7. PubMed ID: 11704403
[TBL] [Abstract][Full Text] [Related]
5. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
Yuki N; Koga M; Hirata K
Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
[TBL] [Abstract][Full Text] [Related]
6. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
[TBL] [Abstract][Full Text] [Related]
7. [Serological study of Campylobacter jejuni infections in patients with Guillain-Barré syndrome].
Takahashi M; Saitoh K; Ohta K; Kudoh Y
Kansenshogaku Zasshi; 1994 Apr; 68(4):467-73. PubMed ID: 8027593
[TBL] [Abstract][Full Text] [Related]
8. [Enzyme-linked immunosorbent assay in the diagnosis of campylobacteriosis].
Jakubczak A; Rastawicki W; Jagielski M
Med Dosw Mikrobiol; 2007; 59(4):359-70. PubMed ID: 18416128
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.
Strid MA; Engberg J; Larsen LB; Begtrup K; Mølbak K; Krogfelt KA
Clin Diagn Lab Immunol; 2001 Mar; 8(2):314-9. PubMed ID: 11238214
[TBL] [Abstract][Full Text] [Related]
11. Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.
Jacobs BC; Koga M; van Rijs W; Geleijns K; van Doorn PA; Willison HJ; Yuki N
J Neuroimmunol; 2008 Feb; 194(1-2):181-90. PubMed ID: 18178257
[TBL] [Abstract][Full Text] [Related]
12. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
[TBL] [Abstract][Full Text] [Related]
13. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis.
Lugaresi A; Ragno M; Torrieri F; Di Guglielmo G; Fermani P; Uncini A
J Neurol Sci; 1997 Apr; 147(2):193-200. PubMed ID: 9106127
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter jejuni enteritis.
Baqar S; Rice B; Lee L; Bourgeois AL; El Din AN; Tribble DR; Heresi GP; Mourad AS; Murphy JR
Clin Infect Dis; 2001 Sep; 33(6):901-5. PubMed ID: 11512097
[TBL] [Abstract][Full Text] [Related]
16. Multifocal motor neuropathy with conduction block and Campylobacter jejuni.
White JR; Sachs GM; Gilchrist JM
Neurology; 1996 Feb; 46(2):562-3. PubMed ID: 8614535
[TBL] [Abstract][Full Text] [Related]
17. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection.
Prendergast MM; Tribble DR; Baqar S; Scott DA; Ferris JA; Walker RI; Moran AP
Infect Immun; 2004 Feb; 72(2):916-22. PubMed ID: 14742536
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
19. [Frequency of antibodies to the recombinant protein P39 of C. jejuni in patients with gastrointestinal disorders and reactive arthritis in Poland].
Rokosz-Chudziak N; Rastawicki W
Med Dosw Mikrobiol; 2014; 66(3-4):195-207. PubMed ID: 25804073
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antibodies reactive with Campylobacter jejuni in Egyptian diarrhea patients.
Ismail TF; Wasfy MO; Oyofo BA; Mansour MM; El-Berry HM; Churilla AM; Eldin SS; Peruski LF
Clin Diagn Lab Immunol; 1997 Sep; 4(5):536-9. PubMed ID: 9302201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
